513 related articles for article (PubMed ID: 3936056)
1. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
[TBL] [Abstract][Full Text] [Related]
2. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
Marten W; Weiss M; Haase W
Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
4. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
Uusitalo A
Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
[TBL] [Abstract][Full Text] [Related]
5. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Akhras F; Chambers J; Jefferies S; Jackson G
Int J Cardiol; 1989 Aug; 24(2):191-6. PubMed ID: 2504673
[TBL] [Abstract][Full Text] [Related]
6. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
[TBL] [Abstract][Full Text] [Related]
7. Assessment of dermal glyceryl trinitrate and isosorbide dinitrate for patients with angina pectoris.
Hubner PJ; Jones PR; Galer IA
Br Med J (Clin Res Ed); 1985 Feb; 290(6467):514-6. PubMed ID: 3918653
[TBL] [Abstract][Full Text] [Related]
8. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
9. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
[TBL] [Abstract][Full Text] [Related]
10. Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
Meffert M; Paeckelmann IM
Drugs; 1987; 33 Suppl 4():104-10. PubMed ID: 3622314
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of nitrates.
Bogaert MG
Cardiovasc Drugs Ther; 1994 Oct; 8(5):693-9. PubMed ID: 7873466
[TBL] [Abstract][Full Text] [Related]
12. A multicentre open comparison of isosorbide-5-mononitrate and nifedipine given prophylactically to general practice patients with chronic stable angina pectoris.
Ankier SI; Fay L; Warrington SJ; Woodings DF
J Int Med Res; 1989; 17(2):172-8. PubMed ID: 2656333
[TBL] [Abstract][Full Text] [Related]
13. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
14. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
van Hasselt M; Weiss M; Haase W
Curr Med Res Opin; 1984; 9(2):107-12. PubMed ID: 6443348
[TBL] [Abstract][Full Text] [Related]
15. [The effect of time and dosage of isosorbide mononitrate on objective and subjective parameters in angina pectoris].
Herrmann H; Kuhl A; Maier-Lenz H
Arzneimittelforschung; 1988 May; 38(5):694-8. PubMed ID: 3415710
[TBL] [Abstract][Full Text] [Related]
16. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
17. Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris.
Ahmadinejad M; Eghbal B; Sorgenicht W; Schneeweiss A; Weiss M
Eur Heart J; 1988 Jan; 9 Suppl A():135-9. PubMed ID: 3137063
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
20. Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
Handler CE; Sullivan ID
Int J Cardiol; 1985 Feb; 7(2):149-57. PubMed ID: 3882583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
